1. The necroptosis-mediated imbalance of mitochondrial dynamics is involved in DEHP-induced toxicity to immature testes via the PGAM5–DRP1 interaction.
- Author
-
Zhou, Xiazhu, Hong, Yifan, Chen, Jing, Yu, Yihang, Wang, Siyuan, Wei, Yuexin, Long, Chunlan, Shen, Lianju, Wu, Shengde, and Wei, Guanghui
- Subjects
MITOCHONDRIA ,TESTIS ,REACTIVE oxygen species ,GONADS ,GERM cells - Abstract
Di-(2-ethylhexyl) phthalate (DEHP) is a widely used plasticizer that has been shown to impair male reproduction, but the potential mechanism underlying testicular injury caused by DEHP remains unclear. In vivo, rats were gavaged consecutively from postnatal day (PND) 21 to PND 31 with 0, 250, or 500 mg/kg DEHP for 10 days, and impaired mitochondria and increased necroptosis were observed in immature testes. In vitro, the GC-1 and GC-2 cell lines were exposed to monoethylhexyl phthalate (MEHP) at 100, 200 and 400 μM for 24 h, and this exposure induced oxidative stress damage, necroptosis and mitochondrial injury. Necroptosis and mitochondrial fission were inhibited by the reactive oxygen species (ROS) inhibitor acetylcysteine, and the imbalanced mitochondrial dynamics were rescued by the RIPK1 inhibitor necrostatin-1. Colocalization and co-IP analyses confirmed an interaction between dynamin-related protein 1 (DRP1) and phosphoglycerate mutase 5 (PGAM5), indicating that PGAM5 dephosphorylates DRP1 at serine 637 to induce mitochondrial fragmentation and thereby induces germ cell damage. Drug prediction with Connectivity Map (cMap) identified sulforaphane as a therapeutic drug. In summary, our findings indicate that DEHP triggers necroptosis and mitochondrial injury via a ROS storm in immature testes and that the PGAM5–DRP1 interaction is involved in this process. [Display omitted] • Necroptosis-induced mitochondrial damage caused DEHP-induced testicular injury. • ROS may be the driving forces for necroptosis and imbalanced mitochondrial dynamics. • PGAM5 promote mitochondrial fission via dephosphorylation of DRP1 S637. • CMap identified sulforaphane as a potential therapeutic drug. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF